Mahmoud Barbir
Overview
Explore the profile of Mahmoud Barbir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Korth J, Steenblock C, Walther R, Barbir M, Husung M, Velthof A
Horm Metab Res
. 2025 Jan;
56(12):e2.
PMID: 39842465
No abstract available.
2.
Korth J, Steenblock C, Walther R, Barbir M, Husung M, Velthof A
Horm Metab Res
. 2024 Dec;
56(12):869-874.
PMID: 39653042
After the COVID-19 pandemic, many patients have reported chronic fatigue and severe post-exertional malaise, with symptoms similar to those of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The accumulation of agonistic receptor...
3.
Barbir M, Pottle A, Bornstein S
Glob Cardiol Sci Pract
. 2024 Oct;
2024(4):e202440.
PMID: 39351468
Lipoprotein(a) (Lp(a)) is a well-recognized causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve stenosis. There are ongoing challenges with screening and management in primary and secondary...
4.
Achleitner M, Steenblock C, Danhardt J, Jarzebska N, Kardashi R, Kanczkowski W, et al.
Mol Psychiatry
. 2023 May;
28(7):2872-2877.
PMID: 37131073
In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of post-infectious complications. Most prominently, millions of patients with Long-Covid complain about chronic fatigue and severe post-exertional...
5.
Neves E, Khan T, Williams M, Carrera M, Banya W, Brugada R, et al.
Glob Cardiol Sci Pract
. 2022 Oct;
2021(4):e202131.
PMID: 36185161
: Familial hypercholesterolaemia (FH) is a common autosomal dominant genetic condition, characterised by elevated LDL cholesterol (LDL-C), leading to premature cardiovascular disease (CVD). Early and accurate diagnosis, with implementation of...
6.
Steenblock C, Walther R, Tselmin S, Jarzebska N, Voit-Bak K, Toepfner N, et al.
Horm Metab Res
. 2022 Sep;
54(11):715-720.
PMID: 36113501
A continual increase in cases of Long/Post COVID constitutes a medical and socioeconomic challenge to health systems around the globe. While the true extent of this problem cannot yet be...
7.
Steenblock C, Hassanein M, Khan E, Yaman M, Kamel M, Barbir M, et al.
Horm Metab Res
. 2022 Jun;
54(8):503-509.
PMID: 35724689
When the corona pandemic commenced more than two years ago, it was quickly recognized that people with metabolic diseases show an augmented risk of severe COVID-19 and an increased mortality...
8.
Steenblock C, Hassanein M, Khan E, Yaman M, Kamel M, Barbir M, et al.
Horm Metab Res
. 2022 Jun;
54(8):496-502.
PMID: 35724688
Obesity is an increasing health problem all over the world. In combination with the current COVID-19 pandemic, this has turned into a massive challenge as individuals with overweight and obesity...
9.
Khan T, Schatz U, Bornstein S, Barbir M
Glob Cardiol Sci Pract
. 2021 Nov;
2021(3):e202119.
PMID: 34805377
Hypertriglyceridaemia represents one of the most prevalent lipid abnormalities, however it is often eclipsed by focus on LDL cholesterol and is frequently overlooked by clinicians, despite it being an important...
10.
Khan T, Hartley A, Haskard D, Caga-Anan M, Pennell D, Collins P, et al.
Antioxidants (Basel)
. 2021 Jan;
10(1).
PMID: 33477712
An abundance of epidemiological evidence demonstrates that elevated lipoprotein(a) (Lp(a)) represents a significant contributing risk factor towards the development of cardiovascular disease. In particular, raised Lp(a) may play a mechanistic...